From Evidence to Implementation: Clarifications Around USPSTF Recommendations for HIV Pre-Exposure Prophylaxis (PrEP) - Episode 1

Introduction: From Evidence to Implementation: Clarifications Around USPSTF Recommendations for HIV Pre-Exposure Prophylaxis (PrEP)

Now Viewing
EP. 1: Introduction: From Evidence to Implementation: Clarifications Around USPSTF Recommendations for HIV Pre-Exposure Prophylaxis (PrEP)
EP. 2: Uptake of HIV PrEP Therapy
EP. 3: Unmet Needs for HIV PrEP Therapy
EP. 4: Barriers to Access for HIV PrEP
EP. 5: Overcoming Barriers to Access HIV PrEP
EP. 6: Role of USPSTF Guidelines for Access to HIV PrEP
EP. 7: Implications of USPSTF Grade A Rating of HIV PrEP
EP. 8: Understanding Implementation of USPSTF Guidelines for HIV PrEP
EP. 9: USPSTF Guidelines for HIV PrEP: Coverage for Drugs vs Ancillary Services
EP. 10: USPSTF Guidelines for HIV PrEP: Using Medical Management Techniques
EP. 11: USPSTF Guidelines: Approaching Optimal Therapy for HIV PrEP
EP. 12: Unmet Needs for USPSTF Guidelines for HIV PrEP
EP. 13: Using Real-World Evidence for HIV PrEP Policies
EP. 14: COVID-19’s Effect on Access to HIV PrEP Therapy
EP. 15: Improving Access and Uptake of HIV PrEP
EP. 16: Overcoming HIV PrEP Access Barriers With Advocacy Groups
EP. 17: Key Takeaways for the Management of HIV PrEP